Jian Tang

Jian Tang is a Chinese AI scientist and entrepreneur who founded BioGeometry, a company applying generative AI to macromolecular drug discovery. According to Gaorong Ventures, Tang established the company in 2022 (some pieces reference 2021) with the stated ambition of building a "ChatGPT for life sciences" — creating programmable large-molecule drugs through geometric deep learning and deep generative models . He holds a tenured associate professorship at the Montreal Institute for Learning Algorithms (Mila) and has served as area chair for leading machine learning conferences including ICML and NeurIPS . Gaorong's earlier coverage described him as among the first scholars internationally to apply deep learning to graph-structured data .

elsewhere's corpus does not cover this subject directly; the above draws from partner institution reporting by Gaorong Ventures.